3 recruiting, 2 active not recruiting, 1 unknown. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Recruiting 3, Active not recruiting 2, Unknown 1 |
Follow Urachal cancer: new trials by email Literature Review of Urachal cancer trials Research Report on Urachal cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies SHR-A1811, Trastuzumab Rezetecan - Urachal Cancer, Advanced Solid Tumor Cancer | Phase 2 | Recruiting | Sheng Zhang | 90 | 2025-12-18 | 2025-12-30 |
| Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors Albumin-paclitaxel Injection - Paget Disease, Extramammary, Rhabdomyosarcoma | Phase 2 | Recruiting | Fudan University | 100 | 2024-11-30 | 2024-12-20 |
| Ivonescimab in the Treatment of Multiple Advanced Tumors Ivocizumab - Pheochromocytoma/Paraganglioma, Rhabdomyosarcoma | Phase 2 | Recruiting | Fudan University | 400 | 2024-11-20 | 2025-08-24 |
| Agnostic Therapy in Rare Solid Tumors Nivolumab - Urachal Cancer, Parathyroid Carcinoma | Phase 2 | Active not recruiting | Instituto do Cancer do Estado de São Paulo | 28 | 2024-07-16 | 2026-10-13 |
| A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer FOLFIRINOX - Urachal Cancer | Phase 2 | Unknown | Asan Medical Center | 35 | 2020-12-01 | 2020-11-02 |
| Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant 5-Fluorouracil (5-FU), Leucovorin, Cisplatin - Bladder Cancer, Urethral Cancer | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 46 | 2003-04-23 | 2025-09-09 |
Paget Disease, Extramammary (3) · Penile Neoplasms (3) · Rhabdomyosarcoma (2) · Sarcoma (2) · Urethral Neoplasms (2) · Adrenal Gland Neoplasms (1) · Angiomyolipoma (1) · Anus Neoplasms (1) · Biliary Tract Neoplasms (1) · Carcinoma (1) · Carcinoma, Adenoid Cystic (1) · Carcinoma, Basal Cell (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Ovarian Epithelial (1)
Neoplasms (5) · Adenocarcinoma (4) · Male Urogenital Diseases (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Glandular and Epithelial (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Carcinoma (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Male (3) · Genital Neoplasms, Male (3) · Neoplasms, Connective and Soft Tissue (3)
Cisplatin (1) · Fluorouracil (1) · Gemcitabine (1) · Leucovorin (1) · Nivolumab (1) · folfirinox (1)
Fudan University (2) · Asan Medical Center (1) · Instituto do Cancer do Estado de São Paulo (1) · M.D. Anderson Cancer Center (1) · Sheng Zhang (1)
China (3) · Brazil (1) · South Korea (1) · United States (1)
Hongxia Wang, Doctor (2) · Arlene Siefker-Radtke, MD (1) · Camila MV Moniz, Doctor (1)
P50CA091846 (1)